Understanding Valneva SE’s Shareholding and Voting Rights
VALNEVA
Declaration of shares and voting rights
__________________________________________________________________________________________
Valneva SE is a notable biopharmaceutical company, striving to advance innovative vaccines and therapies. This article will illuminate the latest updates on their shareholding declaration, focusing on the number of shares and voting rights.
Company Overview
Company name: VALNEVA
Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain
Regulatory Framework
Operating under the regulated market of Euronext Paris - Compartment B, Valneva SE must adhere to stringent regulations that govern public companies. These rules guarantee transparency and accuracy in the reporting of shares and voting rights.
Recent Changes in Shareholding
The declaration is a crucial update that reflects the stock's performance and voter engagement. As of the last report dated January 31, the company had a total of 162,521,524 ordinary shares with a par value of €0.15 each. This significant quantity shows a solid shareholder base, which is paramount for the company's ongoing operations.
Total Voting Rights Overview
In terms of voting rights, Valneva reported a total of 178,407,257 voting rights, which includes those that have been suspended. The analysis of these figures is important for stakeholders as it impacts decision-making during shareholder meetings.
Insights on Voting Rights Changes
There was a notable development where double voting rights were granted on 2,282 ordinary shares last recognized between January 9 and January 24. This change is essential as it enhances the power of certain shareholders and reflects a commitment to rewarding long-term investments.
Understanding Voting Rights Calculation
The voting rights calculation is determined theoretically based on all shares with attached voting rights, including those temporarily suspended. Recognizing these nuances helps investors and stakeholders understand their positions and rights within the company structure.
Implications for Stakeholders
Valneva's active communication about its shares and voting rights underscores a transparent approach favorable to current and potential investors. Engaging with these updates allows stakeholders to make informed decisions and fosters confidence in the company's governance.
Conclusion
As Valneva SE continues its mission to innovate within the pharmaceutical landscape, understanding the shareholding and voting rights framework becomes increasingly vital. Stakeholders should take a keen interest in these regular updates as they reflect the company’s performance and strategic direction.
Frequently Asked Questions
What is the total number of shares for Valneva SE?
The total number of ordinary shares is 162,521,524.
How many voting rights are currently available?
There are 178,407,257 voting rights reported, including those that are suspended.
What does double voting rights imply for shareholders?
Double voting rights enhance the influence of specific shareholders, particularly those with long-term investments.
What is meant by suspended voting rights?
Suspended voting rights refer to shares that are temporarily restricted from voting in shareholder meetings.
Why is the declaration of shares important?
This declaration helps stakeholders understand the company's structure and their respective rights in decision-making processes.
